Sign Up
OverviewAPI
The global oncology drugs market is set to expand rapidly, reaching $474.06 billion by 2030 with a CAGR of 11.53%. Key drivers include the increase in cancer cases, treatment advancements, and tobacco use. Major companies like Bristol Myer Squibb and Roche are investing heavily in R&D and engaging in significant M&A activity.

Ask a question